Between January 2010 and November 2021, we identified 10,116 administrations of R-CHOP-like regimens (R-CHOP, R-THP-COP, and R-CVP) in 2599 patients with DLBCL and FL (Supplementary Fig. 1). The gene discussed is DDIT3; the disease is diffuse large B-cell lymphoma.